methyl palmitate has been researched along with Cardiac Hypertrophy in 1 studies
*Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JC; Chiu, HW; Lee, WS; Lien, CF; Lin, JH; Luo, YP; Ting, PC; Wang, YS; Yang, KT | 1 |
1 other study(ies) available for methyl palmitate and Cardiac Hypertrophy
| Article | Year |
|---|---|
Palmitic acid methyl ester induces cardiac hypertrophy through activating the GPR receptor-mediated changes of intracellular calcium concentrations and mitochondrial functions.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiomegaly; Cells, Cultured; Mitochondria; Myocytes, Cardiac; Palmitates; Rats; Receptors, G-Protein-Coupled | 2023 |